患有帕金森病的患者中的患病率和特征
Sarah Marmol1, Rami Mahmoud2, Matthew Feldman1
1Department of Neurology, University of Miami Miller School of Medicine, Miami, USA.
Acta dermato-venereologica
|November 12, 2025
概括
是帕金森病 (PD) 的常见症状,影响了41%的患者. 较长的PD持续时间与的严重程度增加相关,突出了该病的低估的方面.
科学领域:
- 神经学 神经学
- 皮肤病学 皮肤病学
- 临床医学 临床医学
背景情况:
- 帕金森病 (PD) 患者表现出高度的疼痛敏感性.
- 改变的中央处理和皮肤的α-synuclein是PD中的潜在机制.
- 是一种被低估的症状,影响了PD患者的生活质量.
研究的目的:
- 为了描述帕金森病患者的患病率和严重程度.
- 为了研究和帕金森病的特定特征之间的相关性.
- 为了确定潜在的机制背后的在PD没有皮肤疾病.
主要方法:
- 对100名帕金森病患者的调查,使用修改后的数值 skala.
- 对人口统计数据和疾病特征进行回顾性图表审查.
- 根据慢性报告,将患者分为+和-组.
主要成果:
- 41%的帕金森病患者报告经历.
- 在PD持续时间和24小时平均严重程度之间发现了显著的正相关性 (r=0.491,p=0.002).
- 在研究队列中没有出现皮性皮肤疾病.
结论:
- 是帕金森病的一个普遍症状.
- 帕金森病的持续时间增加与的严重程度增加有关.
- 需要对更大群体进行进一步的研究,以了解PD中的病理机制.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
722
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
722
Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
339
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
339


